The New York Times reports.A final study that could lead to MDMA's legalization as treatment is currently underway; approval could happen as soon as 2023.Researchers and doctors stress that MDMA alone does not aid PTSD sufferers, but must be paired with effective therapy that allows those with the condition to process painful memories and move on from them.
Participants in the study who received MDMA reported less nightmares, panic attacks, and general social anxiety.MDMA was first created by Merck pharmacists in 1912, but mostly neglected by science until the 1970s, when a psychedelic proponent, Alexander Shulgin, synthesized it and tried it himself.